Developmental Genetics of the Pharyngeal Apparatus
Developmental Genetics of the Pharyngeal Apparatus
批准号:
7851312
负责人:
BERNICE E MORROW
金额:
$41.16万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2012-06-30
关键词:
22q1122q11.2Animal ModelAortaBinding SitesBoxingCandidate Disease GeneCardiacCell CommunicationCell Culture TechniquesCell ProliferationCellsComplexCongenital AbnormalityCongenital Heart DefectsConsensusDataDefectDevelopmentDiGeorge SyndromeDistalEmbryoEmbryonic DevelopmentEtiologyFibroblast Growth FactorGene ExpressionGene Expression ProfilingGene FamilyGene TargetingGene Transfer TechniquesGenesGeneticGenetic TranscriptionHeartHeart AtriumHumanIn Situ HybridizationLungMammalian CellMediatingMesenchymeMesoderm CellMolecularMorphogenesisMusMuscleMutant Strains MiceMyocardialNeural CrestNeural Crest CellParathyroid glandPathway interactionsPatientsPharyngeal ApparatusPublic HealthReporterResearchReverse Transcriptase Polymerase Chain ReactionRight ventricular structureRoleShprintzen syndromeSignal TransductionStagingStructureSyndromeSystemTestingThymus GlandTissuesTranscription factor genesTretinoinWild Type Mousebasecell motilitycraniofacialdevelopmental geneticsgain of functiongene interactioninsightinterestmembermutantnovelprematureprogramstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The development of the pharyngeal apparatus into the craniofacial region, thymus, parathyroid and cardiac outflow tract (OFT) involves complex gene interaction, making them highly sensitive to genetic and environmental insults. Velo-cardio-facial syndrome/DiGeorge syndrome is associated with hemizygous 22q11 deletions and characterized by defects in the derivatives of the pharyngeal apparatus. Tbx1, a T-box transcription factor, and the gene for VCFS/DGS in humans, is associated with defects in the same structures when inactivated in the mouse. The most serious defect in patients with the syndrome is OFT defects. Tbx1 is expressed in the multiple tissues in the pharyngeal apparatus including the second heart field (SHF) mesenchyme required for OFT development. The mouse serves as an excellent model organism to identify genes for OFT development because many aspects of its morphogenesis are shared with humans. To identify Tbx1 regulated genetic pathways in the SHF, we performed gene expression profiling of the caudal pharyngeal region in Tbx1-/- and wild type mouse embryos. Isl1, a key marker for the SHF, among selected others, were downregulated in Tbx1-/- mutants, while genes required for posterior specification of the first heart field (FHF), such as Raldh2, Gata4, and Tbx5, as well as a subset of atrial-specific muscle contractile genes were ectopically expressed. Opposite expression changes concomitant with SHF-derived cardiac defects occurred in TBX1 gain-of- function mutants. Based upon these data, we hypothesize that Tbx1 positively regulates SHF cell proliferation and restricts premature differentiation in the caudal pharyngeal mesenchyme. Several genes important for the retinoic acid pathway, transcription factors and novel genes were found in the microarrays. We propose to characterize the most biologically interesting genes in order to build the genetic pathway downstream of Tbx1 in the SHF using null, conditional loss- and gain-of-function mutant mouse embryos. To identify direct downstream target genes of Tbx1, reporter systems will be used in mammalian cells. Tissue interactions are required for neural crest cell (NCC) migration and OFT septation, defective in VCFS/DGS and mouse mutants. Recently, Crkl, another gene deleted on 22q11.2, was shown to mediate Fgf8 signaling downstream of Tbx1. To test this hypothesis in the SHF and in NCCs, embryos with pan-mesodermal and neural crest inactivation of Crkl, respectively, will be analyzed for altered expression of Fgf responsive genes and SHF genes characterized. Using genes identified by microarray studies and conditional mutants we will be able to dissect the genetic pathway of Tbx1 in the SHF and NCCs for OFT development from the pharyngeal apparatus. Narrative: The relevance of this research to public health is that this program will enable us to find genes that cause birth defects. By taking genetics approaches in model organisms, we can obtain insights that would otherwise not be possible in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
-
批准号:10621288
-
项目类别:
-
资助金额:$61.84万
-
财政年份:2022
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
-
批准号:10373375
-
项目类别:
-
资助金额:$79.71万
-
财政年份:2022
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
-
批准号:10553279
-
项目类别:
-
资助金额:$76.31万
-
财政年份:2022
-
负责人:BERNICE E MORROW
-
依托单位:
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
-
批准号:10435713
-
项目类别:
-
资助金额:$61.84万
-
财政年份:2022
-
负责人:BERNICE E MORROW
-
依托单位:
NEUROGENOMICS CORE
-
批准号:10239750
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2021
-
负责人:BERNICE E MORROW
-
依托单位:
NEUROGENOMICS CORE
-
批准号:10455677
-
项目类别:
-
资助金额:$8.55万
-
财政年份:2021
-
负责人:BERNICE E MORROW
-
依托单位:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
-
批准号:10289982
-
项目类别:
-
资助金额:$66.36万
-
财政年份:2021
-
负责人:BERNICE E MORROW
-
依托单位:
NEUROGENOMICS CORE
-
批准号:10669066
-
项目类别:
-
资助金额:$8.55万
-
财政年份:2021
-
负责人:BERNICE E MORROW
-
依托单位:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
-
批准号:10471433
-
项目类别:
-
资助金额:$66.59万
-
财政年份:2021
-
负责人:BERNICE E MORROW
-
依托单位:
Cell fate choices by Tbx1 in forming the mammalian heart
-
批准号:10615781
-
项目类别:
-
资助金额:$60.56万
-
财政年份:2020
-
负责人:BERNICE E MORROW
-
依托单位:
Cell fate choices by Tbx1 in forming the mammalian heart
-
批准号:10242828
-
项目类别:
-
资助金额:$60.56万
-
财政年份:2020
-
负责人:BERNICE E MORROW
-
依托单位:
Cell fate choices by Tbx1 in forming the mammalian heart
-
批准号:10451598
-
项目类别:
-
资助金额:$60.56万
-
财政年份:2020
-
负责人:BERNICE E MORROW
-
依托单位:
Cell fate choices by Tbx1 in forming the mammalian heart
-
批准号:10034059
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2020
-
负责人:BERNICE E MORROW
-
依托单位:
Molecular aspects of CRKL in heart development and human disease
-
批准号:9197022
-
项目类别:
-
资助金额:$81.0万
-
财政年份:2016
-
负责人:BERNICE E MORROW
-
依托单位:
Tbx1 and canonical Wnt signaling in the second heart field
-
批准号:9265548
-
项目类别:
-
资助金额:$70.47万
-
财政年份:2015
-
负责人:BERNICE E MORROW
-
依托单位:
Mouse Models of Human Conotruncal Defects
-
批准号:8231764
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2011
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic Basis of Syndromic and Non-Syndromic Congential Heart Defects
-
批准号:8336919
-
项目类别:
-
资助金额:$132.43万
-
财政年份:2011
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic Basis of Syndromic and Non-Syndromic Congential Heart Defects
-
批准号:8499057
-
项目类别:
-
资助金额:$122.9万
-
财政年份:2011
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic Basis of Syndromic and Non-Syndromic Congential Heart Defects
-
批准号:9188021
-
项目类别:
-
资助金额:$127.43万
-
财政年份:2011
-
负责人:BERNICE E MORROW
-
依托单位:
Genetic Basis of Syndromic and Non-Syndromic Congential Heart Defects
-
批准号:8196192
-
项目类别:
-
资助金额:$141.08万
-
财政年份:2011
-
负责人:BERNICE E MORROW
-
依托单位:
国内基金
海外基金
登录
查看更多内容
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
22q11.2微缺失综合症中T盒转录因子Tbx1与信号接头蛋白Crkl遗传相互作用致肺动脉发育不良缺陷的机制研究
-
批准号:81170153
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:张臻
-
依托单位:
基于染色体22q11.2候选基因与腭心面综合征表型的分子诊断研究
-
批准号:81070813
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:王国民
-
依托单位:
无22q11.2区基因微缺失的心脏圆锥动脉干畸形患者中新TBX1突变体蛋白的功能研究
-
批准号:81070135
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:徐让
-
依托单位:
染色体22q11.2区域泌尿系统畸形关键致病基因的克隆与鉴定
-
批准号:30571867
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:吴斌
-
依托单位: